STOCK TITAN

Electromed (ELMD) CEO Cunniff sells 9,700 shares and exercises stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Electromed, Inc. CEO and President James L. Cunniff reported a combination of stock sales and an option exercise involving the company’s common stock. On June 8, 2026, he sold a total of 9,700 shares in three open-market transactions at weighted average prices of $37.7729, $36.7975, and $36.2490 per share. The same day, he exercised employee stock options to acquire 9,700 shares at an exercise price of $17.25 per share. Following these transactions, he directly holds 147,751 shares of Electromed common stock.

Positive

  • None.

Negative

  • None.
Insider Cunniff James L.
Role CEO and President
Sold 9,700 shs ($354K)
Type Security Shares Price Value
Exercise Employee Stock Option (right to buy) 9,700 $0.00 --
Exercise Common Stock 9,700 $17.25 $167K
Sale Common Stock 7,003 $36.249 $254K
Sale Common Stock 1,671 $36.7975 $61K
Sale Common Stock 1,026 $37.7729 $39K
Holdings After Transaction: Employee Stock Option (right to buy) — 19,400 shares (Direct, null); Common Stock — 157,451 shares (Direct, null)
Footnotes (1)
  1. Reflects the weighted average price of 7,003 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 8, 2026 with sale prices ranging from $35.61 to $36.60 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Reflects the weighted average price of 1,671 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 8, 2026 with sale prices ranging from $36.62 to $37.11 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Reflects the weighted average price of 1,026 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 8, 2026 with sale prices ranging from $37.69 to $38.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Options scheduled to vest and become exercisable in three equal annual installments on each of the first business days of September 2025, 2026 and 2027.
Shares sold 9,700 shares Total Electromed common stock sold on June 8, 2026
Largest sale tranche 7,003 shares at $36.2490 Weighted average price for largest sale block
Other sale tranches 1,671 at $36.7975; 1,026 at $37.7729 Additional open-market sale blocks on June 8, 2026
Options exercised 9,700 shares at $17.25 Employee stock options converted into common stock
Shares held after 147,751 shares Direct Electromed common stock ownership post-transaction
Option expiration 2034-09-03 Expiration date of the reported employee stock option grant
Reported option balance 19,400 options Total employee stock options following derivative transaction entry
open-market sale financial
"transaction_action: "open-market sale" for common stock transactions"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Employee Stock Option (right to buy) financial
"security_title: "Employee Stock Option (right to buy)""
weighted average price financial
"Reflects the weighted average price of 7,003 shares of common stock"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion" for option transactions"
vest and become exercisable financial
"Options scheduled to vest and become exercisable in three equal annual installments"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cunniff James L.

(Last)(First)(Middle)
500 SIXTH AVENUE NW

(Street)
NEW PRAGUE MINNESOTA 56071

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Electromed, Inc. [ ELMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO and President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/08/2026M9,700A$17.25157,451D
Common Stock06/08/2026S7,003D$36.249(1)150,448D
Common Stock06/08/2026S1,671D$36.7975(2)148,777D
Common Stock06/08/2026S1,026D$37.7729(3)147,751D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$17.2506/08/2026M9,700 (4)09/03/2034Common Stock9,700$019,400D
Explanation of Responses:
1. Reflects the weighted average price of 7,003 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 8, 2026 with sale prices ranging from $35.61 to $36.60 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
2. Reflects the weighted average price of 1,671 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 8, 2026 with sale prices ranging from $36.62 to $37.11 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
3. Reflects the weighted average price of 1,026 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 8, 2026 with sale prices ranging from $37.69 to $38.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
4. Options scheduled to vest and become exercisable in three equal annual installments on each of the first business days of September 2025, 2026 and 2027.
/s/ Joshua L. Colburn, Attorney-in-Fact06/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Electromed (ELMD) CEO James L. Cunniff report?

James L. Cunniff reported selling 9,700 Electromed common shares and exercising options for 9,700 shares. The sales were open-market transactions on June 8, 2026, and the option exercise converted derivative awards into common stock at a fixed exercise price.

How many Electromed (ELMD) shares did the CEO sell and at what prices?

The CEO sold 9,700 Electromed common shares in three tranches: 7,003, 1,671 and 1,026 shares. Weighted average sale prices were $36.2490, $36.7975 and $37.7729 per share, based on multiple trades within disclosed price ranges that day.

What stock options did the Electromed (ELMD) CEO exercise in this Form 4?

He exercised employee stock options covering 9,700 Electromed shares at an exercise price of $17.25 per share. These options relate to prior equity awards that were scheduled to vest in three equal annual installments beginning in September 2025.

How many Electromed (ELMD) shares does the CEO hold after these transactions?

After the reported sales and option exercise, James L. Cunniff directly holds 147,751 shares of Electromed common stock. This post-transaction holding reflects his remaining equity stake shown in the Form 4’s ownership column for non-derivative securities.

Were the Electromed (ELMD) CEO’s sales single trades or multiple transactions?

Each reported sale represents multiple trades aggregated into a single line with a weighted average price. Footnotes state sale prices ranged from $35.61 to $38.35 per share, and full trade details are available on request from the CEO or the company.